

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.03539533 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.03539533 |
| 3 | indole-containing compound catabolic process (GO:0042436) | 6.95827254 |
| 4 | indolalkylamine catabolic process (GO:0046218) | 6.95827254 |
| 5 | tryptophan catabolic process (GO:0006569) | 6.95827254 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.94445072 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.69826931 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 6.69826931 |
| 9 | tryptophan metabolic process (GO:0006568) | 6.55480542 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.17591989 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.94137175 |
| 12 | drug transmembrane transport (GO:0006855) | 5.93439604 |
| 13 | urate metabolic process (GO:0046415) | 5.87010981 |
| 14 | behavioral response to nicotine (GO:0035095) | 5.78512102 |
| 15 | cysteine metabolic process (GO:0006534) | 5.25808806 |
| 16 | lysine catabolic process (GO:0006554) | 5.22767685 |
| 17 | lysine metabolic process (GO:0006553) | 5.22767685 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.22178923 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.20758555 |
| 20 | cellular biogenic amine catabolic process (GO:0042402) | 5.14802254 |
| 21 | amine catabolic process (GO:0009310) | 5.14802254 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14759326 |
| 23 | indolalkylamine metabolic process (GO:0006586) | 5.10009092 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 5.05845225 |
| 25 | L-fucose catabolic process (GO:0042355) | 4.96902316 |
| 26 | fucose catabolic process (GO:0019317) | 4.96902316 |
| 27 | L-fucose metabolic process (GO:0042354) | 4.96902316 |
| 28 | amino-acid betaine metabolic process (GO:0006577) | 4.96875515 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.96046637 |
| 30 | drug transport (GO:0015893) | 4.83654280 |
| 31 | drug catabolic process (GO:0042737) | 4.76701278 |
| 32 | alpha-amino acid catabolic process (GO:1901606) | 4.65535941 |
| 33 | DNA deamination (GO:0045006) | 4.60506658 |
| 34 | urea cycle (GO:0000050) | 4.48277800 |
| 35 | urea metabolic process (GO:0019627) | 4.48277800 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.37999444 |
| 37 | bile acid metabolic process (GO:0008206) | 4.36233844 |
| 38 | response to pheromone (GO:0019236) | 4.35292548 |
| 39 | cellular glucuronidation (GO:0052695) | 4.33228147 |
| 40 | exogenous drug catabolic process (GO:0042738) | 4.27398588 |
| 41 | short-chain fatty acid metabolic process (GO:0046459) | 4.25515719 |
| 42 | cellular amino acid catabolic process (GO:0009063) | 4.25071975 |
| 43 | benzene-containing compound metabolic process (GO:0042537) | 4.24311737 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.23985504 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 4.23348046 |
| 46 | NAD biosynthetic process (GO:0009435) | 4.23300504 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 4.14758164 |
| 48 | aldehyde catabolic process (GO:0046185) | 4.13127746 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.13081571 |
| 50 | serine family amino acid metabolic process (GO:0009069) | 4.07445080 |
| 51 | uronic acid metabolic process (GO:0006063) | 4.06624812 |
| 52 | glucuronate metabolic process (GO:0019585) | 4.06624812 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 4.04213627 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.03981233 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 3.99949905 |
| 56 | glutamate metabolic process (GO:0006536) | 3.99670896 |
| 57 | regulation of fibrinolysis (GO:0051917) | 3.98910302 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.98365699 |
| 59 | protein carboxylation (GO:0018214) | 3.98365699 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 3.95512111 |
| 61 | organic cation transport (GO:0015695) | 3.92062734 |
| 62 | regulation of bile acid biosynthetic process (GO:0070857) | 3.90381543 |
| 63 | high-density lipoprotein particle remodeling (GO:0034375) | 3.90157614 |
| 64 | carnitine metabolic process (GO:0009437) | 3.88076022 |
| 65 | regulation of protein activation cascade (GO:2000257) | 3.86554506 |
| 66 | carboxylic acid catabolic process (GO:0046395) | 3.82644199 |
| 67 | organic acid catabolic process (GO:0016054) | 3.82644199 |
| 68 | triglyceride homeostasis (GO:0070328) | 3.82098660 |
| 69 | acylglycerol homeostasis (GO:0055090) | 3.82098660 |
| 70 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.80881914 |
| 71 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.80881914 |
| 72 | indole-containing compound metabolic process (GO:0042430) | 3.79549607 |
| 73 | coenzyme catabolic process (GO:0009109) | 3.77453790 |
| 74 | complement activation, alternative pathway (GO:0006957) | 3.76375246 |
| 75 | fatty acid beta-oxidation (GO:0006635) | 3.74564590 |
| 76 | alpha-linolenic acid metabolic process (GO:0036109) | 3.73695915 |
| 77 | negative regulation of fibrinolysis (GO:0051918) | 3.72556443 |
| 78 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.70268817 |
| 79 | aspartate family amino acid catabolic process (GO:0009068) | 3.65070852 |
| 80 | fatty acid oxidation (GO:0019395) | 3.64476016 |
| 81 | lipid oxidation (GO:0034440) | 3.59671870 |
| 82 | branched-chain amino acid metabolic process (GO:0009081) | 3.59370916 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 3.58911901 |
| 84 | glycine metabolic process (GO:0006544) | 3.58615639 |
| 85 | valine metabolic process (GO:0006573) | 3.57566133 |
| 86 | branched-chain amino acid catabolic process (GO:0009083) | 3.55944568 |
| 87 | regulation of complement activation (GO:0030449) | 3.55161608 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 3.55051264 |
| 89 | monocarboxylic acid catabolic process (GO:0072329) | 3.54850683 |
| 90 | arginine metabolic process (GO:0006525) | 3.52776044 |
| 91 | bile acid and bile salt transport (GO:0015721) | 3.52503695 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.52270211 |
| 93 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51397232 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.51020396 |
| 95 | response to mercury ion (GO:0046689) | 3.50619522 |
| 96 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.50065892 |
| 97 | negative regulation of cholesterol transport (GO:0032375) | 3.46183561 |
| 98 | negative regulation of sterol transport (GO:0032372) | 3.46183561 |
| 99 | ketone body metabolic process (GO:1902224) | 3.43876965 |
| 100 | plasma lipoprotein particle remodeling (GO:0034369) | 3.43012521 |
| 101 | protein-lipid complex remodeling (GO:0034368) | 3.43012521 |
| 102 | macromolecular complex remodeling (GO:0034367) | 3.43012521 |
| 103 | reverse cholesterol transport (GO:0043691) | 3.40516639 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.40278489 |
| 105 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.40024997 |
| 106 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.38630290 |
| 107 | phosphate ion transport (GO:0006817) | 3.37366464 |
| 108 | 2-oxoglutarate metabolic process (GO:0006103) | 3.36820645 |
| 109 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.36281288 |
| 110 | ethanol oxidation (GO:0006069) | 3.32607510 |
| 111 | small molecule catabolic process (GO:0044282) | 3.27206923 |
| 112 | negative regulation of telomere maintenance (GO:0032205) | 3.25549109 |
| 113 | nephron epithelium morphogenesis (GO:0072088) | 3.23777476 |
| 114 | nephron tubule morphogenesis (GO:0072078) | 3.23777476 |
| 115 | platelet dense granule organization (GO:0060155) | 3.23360630 |
| 116 | protein complex biogenesis (GO:0070271) | 3.21813753 |
| 117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.17695472 |
| 118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.17695472 |
| 119 | NADH dehydrogenase complex assembly (GO:0010257) | 3.17695472 |
| 120 | axoneme assembly (GO:0035082) | 3.09098196 |
| 121 | negative regulation of mast cell activation (GO:0033004) | 3.04276440 |
| 122 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.02708543 |
| 123 | protein polyglutamylation (GO:0018095) | 3.01582728 |
| 124 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.00861521 |
| 125 | detection of light stimulus involved in visual perception (GO:0050908) | 3.00861521 |
| 126 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.00571455 |
| 127 | neuronal action potential (GO:0019228) | 2.97616202 |
| 128 | protein-cofactor linkage (GO:0018065) | 2.94306646 |
| 129 | sulfation (GO:0051923) | 2.93577947 |
| 130 | respiratory chain complex IV assembly (GO:0008535) | 2.91251935 |
| 131 | regulation of cilium movement (GO:0003352) | 2.90319420 |
| 132 | synaptic transmission, cholinergic (GO:0007271) | 2.89397416 |
| 133 | epithelial cilium movement (GO:0003351) | 2.88516122 |
| 134 | protein K11-linked deubiquitination (GO:0035871) | 2.85298932 |
| 135 | fucosylation (GO:0036065) | 2.83956685 |
| 136 | piRNA metabolic process (GO:0034587) | 2.83055561 |
| 137 | regulation of action potential (GO:0098900) | 2.81349505 |
| 138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.80998054 |
| 139 | primary amino compound metabolic process (GO:1901160) | 2.76946865 |
| 140 | ubiquinone biosynthetic process (GO:0006744) | 2.76890021 |
| 141 | cellular response to ATP (GO:0071318) | 2.72692760 |
| 142 | multicellular organism reproduction (GO:0032504) | 2.71953536 |
| 143 | kidney morphogenesis (GO:0060993) | 2.69868667 |
| 144 | regulation of mesoderm development (GO:2000380) | 2.69755098 |
| 145 | retinal cone cell development (GO:0046549) | 2.68907844 |
| 146 | rRNA catabolic process (GO:0016075) | 2.68338456 |
| 147 | alanine transport (GO:0032328) | 2.67891564 |
| 148 | behavioral response to ethanol (GO:0048149) | 2.67446470 |
| 149 | proline transport (GO:0015824) | 2.66466488 |
| 150 | regulation of hexokinase activity (GO:1903299) | 2.63383316 |
| 151 | regulation of glucokinase activity (GO:0033131) | 2.63383316 |
| 152 | cytochrome complex assembly (GO:0017004) | 2.62945547 |
| 153 | membrane depolarization during action potential (GO:0086010) | 2.62764226 |
| 154 | mannosylation (GO:0097502) | 2.62492523 |
| 155 | renal tubule morphogenesis (GO:0061333) | 2.60776852 |
| 156 | reciprocal DNA recombination (GO:0035825) | 2.57321536 |
| 157 | reciprocal meiotic recombination (GO:0007131) | 2.57321536 |
| 158 | ubiquinone metabolic process (GO:0006743) | 2.57069420 |
| 159 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.56222411 |
| 160 | protein localization to cilium (GO:0061512) | 2.56192166 |
| 161 | positive regulation of fatty acid transport (GO:2000193) | 2.55839299 |
| 162 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.55160800 |
| 163 | spinal cord motor neuron differentiation (GO:0021522) | 2.54335564 |
| 164 | nonmotile primary cilium assembly (GO:0035058) | 2.53666945 |
| 165 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.53522353 |
| 166 | photoreceptor cell development (GO:0042461) | 2.53364541 |
| 167 | sperm motility (GO:0030317) | 2.53282745 |
| 168 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.52902546 |
| 169 | auditory receptor cell stereocilium organization (GO:0060088) | 2.52735088 |
| 170 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.52673091 |
| 171 | ATP synthesis coupled proton transport (GO:0015986) | 2.52673091 |
| 172 | transepithelial transport (GO:0070633) | 2.52272036 |
| 173 | male meiosis I (GO:0007141) | 2.50094954 |
| 174 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.49610780 |
| 175 | dopamine transport (GO:0015872) | 2.47143779 |
| 176 | cilium morphogenesis (GO:0060271) | 2.46978922 |
| 177 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.46639528 |
| 178 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.46380057 |
| 179 | cilium movement (GO:0003341) | 2.46262118 |
| 180 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.45811615 |
| 181 | reflex (GO:0060004) | 2.45537302 |
| 182 | rhodopsin mediated signaling pathway (GO:0016056) | 2.43876018 |
| 183 | basic amino acid transport (GO:0015802) | 2.41154511 |
| 184 | action potential (GO:0001508) | 2.40666717 |
| 185 | photoreceptor cell maintenance (GO:0045494) | 2.39572983 |
| 186 | L-methionine biosynthetic process (GO:0071265) | 2.38810591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.08009140 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.75574427 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.60310067 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.57384629 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.14575053 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.41906164 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.13635301 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08893121 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.41658406 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.31971993 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.97989930 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.60422678 |
| 13 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.07474963 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.02406986 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92667149 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.85522660 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81420767 |
| 18 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.79608714 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74889460 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.73322396 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 1.71585859 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70669971 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68471562 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65160665 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64603776 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62557536 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.61632051 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56730213 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54615905 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52610553 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.52536026 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52523785 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.50141552 |
| 34 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.49264270 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.49016932 |
| 36 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48500855 |
| 37 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48500855 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48094725 |
| 39 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.47419285 |
| 40 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.47419285 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43775197 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42507912 |
| 43 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41837661 |
| 44 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41837661 |
| 45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.41626565 |
| 46 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.41359275 |
| 47 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.40574139 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39145793 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38149619 |
| 50 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37672549 |
| 51 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.37281669 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37057814 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36684478 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36544715 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35042312 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34889573 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34603690 |
| 58 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.34515161 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32371784 |
| 60 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.29396763 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.29338727 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29292976 |
| 63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29292217 |
| 64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28771346 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27091722 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27081746 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26058593 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23582703 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23331767 |
| 70 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.23093574 |
| 71 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.22674663 |
| 72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22036750 |
| 73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20354962 |
| 74 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19904191 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19816881 |
| 76 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18880417 |
| 77 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18368678 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17827723 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17515369 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17515044 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17094864 |
| 82 | ERA_21632823_ChIP-Seq_H3396_Human | 1.17065850 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16506245 |
| 84 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15699670 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14957875 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14557241 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13591787 |
| 88 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.13571468 |
| 89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.13510881 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12615509 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12339625 |
| 92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.11758807 |
| 93 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11493361 |
| 94 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.11404720 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09801570 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08760819 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08617617 |
| 98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08497117 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07957814 |
| 100 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.04057005 |
| 101 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03920258 |
| 102 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03723348 |
| 103 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03486147 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02995801 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02961181 |
| 106 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.02874606 |
| 107 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01740282 |
| 108 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01595511 |
| 109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01419089 |
| 110 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.01067409 |
| 111 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.00479596 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00352577 |
| 113 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00049295 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99987720 |
| 115 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.99979411 |
| 116 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99838908 |
| 117 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99722982 |
| 118 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99695573 |
| 119 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99458754 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99193586 |
| 121 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.98905298 |
| 122 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98246945 |
| 123 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97913593 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97829093 |
| 125 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97039874 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97020931 |
| 127 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.96778380 |
| 128 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.96045317 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94429635 |
| 130 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.91933293 |
| 131 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91770633 |
| 132 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90818332 |
| 133 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.90812719 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89309388 |
| 135 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87692356 |
| 136 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.87546658 |
| 137 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.87133669 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85348152 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84925986 |
| 140 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.84283386 |
| 141 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83884815 |
| 142 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.83287300 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83285846 |
| 144 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81290508 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80784794 |
| 146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79849763 |
| 147 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79527784 |
| 148 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.78732318 |
| 149 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.78725540 |
| 150 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.78713443 |
| 151 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77914966 |
| 152 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.76881236 |
| 153 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.76030652 |
| 154 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75341989 |
| 155 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75341989 |
| 156 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74422320 |
| 157 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.73430844 |
| 158 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.71788206 |
| 159 | P300_19829295_ChIP-Seq_ESCs_Human | 0.71150811 |
| 160 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70692900 |
| 161 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.69593318 |
| 162 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68669709 |
| 163 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.68621708 |
| 164 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.68075685 |
| 165 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.67950137 |
| 166 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.67172965 |
| 167 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.66495130 |
| 168 | KDM2B_26808549_Chip-Seq_REH_Human | 0.65894150 |
| 169 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.65293038 |
| 170 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.63885138 |
| 171 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.62422019 |
| 172 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62224680 |
| 173 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.61794947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.50433630 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.19298742 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.59232117 |
| 4 | MP0005365_abnormal_bile_salt | 5.27417685 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.53315033 |
| 6 | MP0003195_calcinosis | 4.23560759 |
| 7 | MP0003252_abnormal_bile_duct | 3.89810286 |
| 8 | MP0003283_abnormal_digestive_organ | 3.70005649 |
| 9 | MP0005332_abnormal_amino_acid | 3.62786947 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.39798880 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.37682236 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 3.22471355 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.56006010 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.45911787 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.40091414 |
| 16 | MP0002102_abnormal_ear_morphology | 2.39470076 |
| 17 | MP0004043_abnormal_pH_regulation | 2.37080894 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.36395485 |
| 19 | MP0009643_abnormal_urine_homeostasis | 2.16398456 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.00308410 |
| 21 | MP0009745_abnormal_behavioral_response | 1.98106205 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.95641747 |
| 23 | MP0001764_abnormal_homeostasis | 1.93496772 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.92218123 |
| 25 | MP0002736_abnormal_nociception_after | 1.89123334 |
| 26 | MP0005083_abnormal_biliary_tract | 1.88808510 |
| 27 | MP0009046_muscle_twitch | 1.88620660 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.82820820 |
| 29 | MP0002272_abnormal_nervous_system | 1.77090687 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.76988764 |
| 31 | MP0009697_abnormal_copulation | 1.76059944 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.71169098 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.70946640 |
| 34 | MP0004885_abnormal_endolymph | 1.70550977 |
| 35 | MP0004142_abnormal_muscle_tone | 1.67617868 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.67207593 |
| 37 | MP0004133_heterotaxia | 1.65971554 |
| 38 | MP0009840_abnormal_foam_cell | 1.65942182 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.64875274 |
| 40 | MP0005451_abnormal_body_composition | 1.63759946 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.63360474 |
| 42 | MP0003880_abnormal_central_pattern | 1.63290792 |
| 43 | MP0000609_abnormal_liver_physiology | 1.62418772 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.58596294 |
| 45 | MP0003186_abnormal_redox_activity | 1.56406781 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.56165045 |
| 47 | MP0009764_decreased_sensitivity_to | 1.55140353 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54866447 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.53517926 |
| 50 | MP0005253_abnormal_eye_physiology | 1.51985879 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.49620409 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.46638916 |
| 53 | MP0002938_white_spotting | 1.45404099 |
| 54 | MP0005410_abnormal_fertilization | 1.44208352 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.42404686 |
| 56 | MP0005647_abnormal_sex_gland | 1.39436214 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.39176352 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.38965157 |
| 59 | MP0003868_abnormal_feces_composition | 1.38826993 |
| 60 | MP0001756_abnormal_urination | 1.38671830 |
| 61 | MP0001970_abnormal_pain_threshold | 1.37725001 |
| 62 | MP0002064_seizures | 1.37353915 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.36280277 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.35697255 |
| 65 | MP0002136_abnormal_kidney_physiology | 1.35411386 |
| 66 | MP0001486_abnormal_startle_reflex | 1.32103216 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.31034998 |
| 68 | MP0005670_abnormal_white_adipose | 1.30236251 |
| 69 | MP0002557_abnormal_social/conspecific_i | 1.28846881 |
| 70 | MP0001765_abnormal_ion_homeostasis | 1.28028180 |
| 71 | MP0003787_abnormal_imprinting | 1.25797017 |
| 72 | MP0001905_abnormal_dopamine_level | 1.23506533 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.23268627 |
| 74 | MP0000427_abnormal_hair_cycle | 1.23187364 |
| 75 | MP0004742_abnormal_vestibular_system | 1.20953307 |
| 76 | MP0003724_increased_susceptibility_to | 1.18621259 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.16433396 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 1.12111693 |
| 79 | MP0001529_abnormal_vocalization | 1.10680567 |
| 80 | MP0002234_abnormal_pharynx_morphology | 1.09803588 |
| 81 | MP0002254_reproductive_system_inflammat | 1.09093707 |
| 82 | MP0004924_abnormal_behavior | 1.08434961 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.08434961 |
| 84 | MP0008775_abnormal_heart_ventricle | 1.07420227 |
| 85 | MP0002928_abnormal_bile_duct | 1.06581554 |
| 86 | MP0005423_abnormal_somatic_nervous | 1.05973868 |
| 87 | MP0002067_abnormal_sensory_capabilities | 1.05970564 |
| 88 | MP0003119_abnormal_digestive_system | 1.05664851 |
| 89 | MP0002160_abnormal_reproductive_system | 1.05455501 |
| 90 | MP0002751_abnormal_autonomic_nervous | 1.04881629 |
| 91 | MP0001984_abnormal_olfaction | 1.04634706 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 1.04286822 |
| 93 | MP0002063_abnormal_learning/memory/cond | 1.04107770 |
| 94 | MP0003635_abnormal_synaptic_transmissio | 1.03486294 |
| 95 | MP0004215_abnormal_myocardial_fiber | 1.00061731 |
| 96 | MP0005389_reproductive_system_phenotype | 0.98995192 |
| 97 | MP0005195_abnormal_posterior_eye | 0.98427953 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.97683043 |
| 99 | MP0008469_abnormal_protein_level | 0.96056754 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.93700450 |
| 101 | MP0003698_abnormal_male_reproductive | 0.90843600 |
| 102 | MP0000566_synostosis | 0.90497566 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 0.89905829 |
| 104 | MP0004085_abnormal_heartbeat | 0.89671614 |
| 105 | MP0002229_neurodegeneration | 0.88734195 |
| 106 | MP0005408_hypopigmentation | 0.88478581 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.87718349 |
| 108 | MP0003122_maternal_imprinting | 0.87567751 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.87554888 |
| 110 | MP0000026_abnormal_inner_ear | 0.85648131 |
| 111 | MP0009763_increased_sensitivity_to | 0.85283713 |
| 112 | MP0003878_abnormal_ear_physiology | 0.85000217 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.85000217 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.83496080 |
| 115 | MP0000049_abnormal_middle_ear | 0.83371788 |
| 116 | MP0000598_abnormal_liver_morphology | 0.83132429 |
| 117 | MP0003011_delayed_dark_adaptation | 0.82944173 |
| 118 | MP0002184_abnormal_innervation | 0.80007826 |
| 119 | MP0001324_abnormal_eye_pigmentation | 0.79790294 |
| 120 | MP0001963_abnormal_hearing_physiology | 0.79646652 |
| 121 | MP0000383_abnormal_hair_follicle | 0.79054116 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.76413011 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.75385606 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.74610819 |
| 125 | MP0010368_abnormal_lymphatic_system | 0.73703223 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.73401390 |
| 127 | MP0001661_extended_life_span | 0.72783901 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.72537053 |
| 129 | MP0005535_abnormal_body_temperature | 0.70846842 |
| 130 | MP0002168_other_aberrant_phenotype | 0.70687610 |
| 131 | MP0004147_increased_porphyrin_level | 0.70573950 |
| 132 | MP0004381_abnormal_hair_follicle | 0.66014724 |
| 133 | MP0005395_other_phenotype | 0.65997442 |
| 134 | MP0006292_abnormal_olfactory_placode | 0.64295634 |
| 135 | MP0005334_abnormal_fat_pad | 0.63719826 |
| 136 | MP0010386_abnormal_urinary_bladder | 0.59705233 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.57897665 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.53336319 |
| 139 | MP0003953_abnormal_hormone_level | 0.52918375 |
| 140 | MP0001835_abnormal_antigen_presentation | 0.50705560 |
| 141 | MP0000678_abnormal_parathyroid_gland | 0.49956801 |
| 142 | MP0008260_abnormal_autophagy | 0.48020362 |
| 143 | MP0002132_abnormal_respiratory_system | 0.47215024 |
| 144 | MP0002135_abnormal_kidney_morphology | 0.46034780 |
| 145 | MP0006082_CNS_inflammation | 0.45910677 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.45130907 |
| 147 | MP0009785_altered_susceptibility_to | 0.44332220 |
| 148 | MP0002971_abnormal_brown_adipose | 0.44302941 |
| 149 | MP0001790_abnormal_immune_system | 0.43886918 |
| 150 | MP0005387_immune_system_phenotype | 0.43886918 |
| 151 | MP0003638_abnormal_response/metabolism_ | 0.42084095 |
| 152 | MP0003718_maternal_effect | 0.41888660 |
| 153 | MP0003690_abnormal_glial_cell | 0.41826954 |
| 154 | MP0001986_abnormal_taste_sensitivity | 0.41604851 |
| 155 | MP0003646_muscle_fatigue | 0.39890939 |
| 156 | MP0003879_abnormal_hair_cell | 0.39352491 |
| 157 | MP0006035_abnormal_mitochondrial_morpho | 0.36628593 |
| 158 | MP0001944_abnormal_pancreas_morphology | 0.34636405 |
| 159 | MP0001879_abnormal_lymphatic_vessel | 0.34229993 |
| 160 | MP0001177_atelectasis | 0.32958144 |
| 161 | MP0002098_abnormal_vibrissa_morphology | 0.32467248 |
| 162 | MP0009115_abnormal_fat_cell | 0.31869032 |
| 163 | MP0005075_abnormal_melanosome_morpholog | 0.31751528 |
| 164 | MP0000579_abnormal_nail_morphology | 0.31488428 |
| 165 | MP0000371_diluted_coat_color | 0.31068151 |
| 166 | MP0003656_abnormal_erythrocyte_physiolo | 0.29663600 |
| 167 | MP0003136_yellow_coat_color | 0.29376755 |
| 168 | MP0008872_abnormal_physiological_respon | 0.29362885 |
| 169 | MP0005448_abnormal_energy_balance | 0.29348240 |
| 170 | MP0001919_abnormal_reproductive_system | 0.28141559 |
| 171 | MP0003436_decreased_susceptibility_to | 0.28082412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.66200359 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.36545172 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.81673454 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.68752831 |
| 5 | Hyperglycinuria (HP:0003108) | 4.68035407 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.46332415 |
| 7 | Pancreatic cysts (HP:0001737) | 4.28210136 |
| 8 | Joint hemorrhage (HP:0005261) | 4.17043801 |
| 9 | Xanthomatosis (HP:0000991) | 4.16081382 |
| 10 | Deep venous thrombosis (HP:0002625) | 4.13954374 |
| 11 | Gout (HP:0001997) | 4.08629490 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07819633 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.07819633 |
| 14 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.99816968 |
| 15 | Hyperglycinemia (HP:0002154) | 3.95543637 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.94160343 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.92093849 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.87246436 |
| 19 | Proximal tubulopathy (HP:0000114) | 3.84003336 |
| 20 | Pancreatic fibrosis (HP:0100732) | 3.81336754 |
| 21 | Ketosis (HP:0001946) | 3.79747605 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 3.77867114 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 3.77867114 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.73647213 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64323368 |
| 26 | True hermaphroditism (HP:0010459) | 3.61568892 |
| 27 | Hyperammonemia (HP:0001987) | 3.61274826 |
| 28 | Alkalosis (HP:0001948) | 3.55935562 |
| 29 | Hypokalemic alkalosis (HP:0001949) | 3.52246796 |
| 30 | Abnormality of purine metabolism (HP:0004352) | 3.51725312 |
| 31 | Nephronophthisis (HP:0000090) | 3.51523524 |
| 32 | Hyperactive renin-angiotensin system (HP:0000841) | 3.50899826 |
| 33 | Metabolic alkalosis (HP:0200114) | 3.44478974 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.43889682 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 3.40834248 |
| 36 | Increased circulating renin level (HP:0000848) | 3.34946790 |
| 37 | Polyuria (HP:0000103) | 3.33255530 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 3.32163238 |
| 39 | Ketoacidosis (HP:0001993) | 3.31164765 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 3.30566684 |
| 41 | Hypomagnesemia (HP:0002917) | 3.30110738 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.28218422 |
| 43 | Abnormal urine output (HP:0012590) | 3.26779473 |
| 44 | Type II lissencephaly (HP:0007260) | 3.24945657 |
| 45 | Vascular calcification (HP:0004934) | 3.22907315 |
| 46 | Hypoglycemic coma (HP:0001325) | 3.19543936 |
| 47 | Epidermoid cyst (HP:0200040) | 3.16284288 |
| 48 | Clumsiness (HP:0002312) | 3.13213631 |
| 49 | Glycosuria (HP:0003076) | 3.13070271 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 3.13070271 |
| 51 | Complement deficiency (HP:0004431) | 3.08123919 |
| 52 | Delayed CNS myelination (HP:0002188) | 3.04670220 |
| 53 | Abnormality of renal excretion (HP:0011036) | 3.04592643 |
| 54 | Fat malabsorption (HP:0002630) | 3.03556988 |
| 55 | Renal cortical cysts (HP:0000803) | 3.03035274 |
| 56 | Increased purine levels (HP:0004368) | 3.00121030 |
| 57 | Hyperuricemia (HP:0002149) | 3.00121030 |
| 58 | Abnormality of chloride homeostasis (HP:0011422) | 2.98824818 |
| 59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.97957279 |
| 60 | Abnormality of alanine metabolism (HP:0010916) | 2.97957279 |
| 61 | Hyperalaninemia (HP:0003348) | 2.97957279 |
| 62 | Abnormality of the renal medulla (HP:0100957) | 2.96002742 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.94469546 |
| 64 | Enlarged kidneys (HP:0000105) | 2.92948174 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.91135341 |
| 66 | Abolished electroretinogram (ERG) (HP:0000550) | 2.86954845 |
| 67 | Metabolic acidosis (HP:0001942) | 2.86043538 |
| 68 | Decreased circulating renin level (HP:0003351) | 2.82980882 |
| 69 | Abnormal drinking behavior (HP:0030082) | 2.80229136 |
| 70 | Polydipsia (HP:0001959) | 2.80229136 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.76725857 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76613077 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.76613077 |
| 74 | Cystic liver disease (HP:0006706) | 2.74459744 |
| 75 | Abnormality of magnesium homeostasis (HP:0004921) | 2.70383379 |
| 76 | Pendular nystagmus (HP:0012043) | 2.68776669 |
| 77 | Rickets (HP:0002748) | 2.68463927 |
| 78 | Inability to walk (HP:0002540) | 2.67767534 |
| 79 | Hyperventilation (HP:0002883) | 2.66383595 |
| 80 | Hyperbilirubinemia (HP:0002904) | 2.64762441 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 2.63112746 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.62393360 |
| 83 | Lethargy (HP:0001254) | 2.61676127 |
| 84 | Tubular atrophy (HP:0000092) | 2.61227379 |
| 85 | Hypophosphatemic rickets (HP:0004912) | 2.59784785 |
| 86 | Large for gestational age (HP:0001520) | 2.59636187 |
| 87 | Hypolipoproteinemia (HP:0010981) | 2.58813780 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 2.55097833 |
| 89 | Congenital, generalized hypertrichosis (HP:0004540) | 2.50983434 |
| 90 | Hypoglycemic seizures (HP:0002173) | 2.48585595 |
| 91 | Tetany (HP:0001281) | 2.47490561 |
| 92 | Renal tubular acidosis (HP:0001947) | 2.47484114 |
| 93 | Decreased central vision (HP:0007663) | 2.46042547 |
| 94 | Medial flaring of the eyebrow (HP:0010747) | 2.42769924 |
| 95 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41086333 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.40626274 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.40626274 |
| 98 | Progressive inability to walk (HP:0002505) | 2.39369453 |
| 99 | Hypoalphalipoproteinemia (HP:0003233) | 2.38412078 |
| 100 | Abnormality of renin-angiotensin system (HP:0000847) | 2.38349254 |
| 101 | Hyperaldosteronism (HP:0000859) | 2.38010526 |
| 102 | Sclerocornea (HP:0000647) | 2.37679600 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.36430538 |
| 104 | Cerebellar dysplasia (HP:0007033) | 2.35826837 |
| 105 | Methylmalonic aciduria (HP:0012120) | 2.32800380 |
| 106 | Mitochondrial inheritance (HP:0001427) | 2.32587510 |
| 107 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30000284 |
| 108 | Symptomatic seizures (HP:0011145) | 2.29530260 |
| 109 | Increased CSF lactate (HP:0002490) | 2.28775706 |
| 110 | Vomiting (HP:0002013) | 2.28614734 |
| 111 | Abnormality of the renal cortex (HP:0011035) | 2.27375617 |
| 112 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.23401631 |
| 113 | Abnormality of renal resorption (HP:0011038) | 2.23104554 |
| 114 | Steatorrhea (HP:0002570) | 2.21887210 |
| 115 | Hyperphosphaturia (HP:0003109) | 2.21753360 |
| 116 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.20628497 |
| 117 | Absent/shortened dynein arms (HP:0200106) | 2.20628497 |
| 118 | Hypercholesterolemia (HP:0003124) | 2.20178852 |
| 119 | Increased corneal curvature (HP:0100692) | 2.19649953 |
| 120 | Keratoconus (HP:0000563) | 2.19649953 |
| 121 | Methylmalonic acidemia (HP:0002912) | 2.17969316 |
| 122 | Abnormal urine phosphate concentration (HP:0012599) | 2.17407732 |
| 123 | Gaze-evoked nystagmus (HP:0000640) | 2.16669915 |
| 124 | Acute necrotizing encephalopathy (HP:0006965) | 2.15708956 |
| 125 | Hypophosphatemia (HP:0002148) | 2.15708599 |
| 126 | Cerebral edema (HP:0002181) | 2.15616806 |
| 127 | Disproportionate short-trunk short stature (HP:0003521) | 2.15350125 |
| 128 | Abnormality of complement system (HP:0005339) | 2.13913035 |
| 129 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.13291056 |
| 130 | Myocardial infarction (HP:0001658) | 2.13244908 |
| 131 | Chronic hepatic failure (HP:0100626) | 2.13148983 |
| 132 | Bile duct proliferation (HP:0001408) | 2.12535152 |
| 133 | Abnormal biliary tract physiology (HP:0012439) | 2.12535152 |
| 134 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.11940559 |
| 135 | Abnormality of the pons (HP:0007361) | 2.10918854 |
| 136 | Renal tubular dysfunction (HP:0000124) | 2.10547719 |
| 137 | Concave nail (HP:0001598) | 2.07939637 |
| 138 | Furrowed tongue (HP:0000221) | 2.07615898 |
| 139 | Confusion (HP:0001289) | 2.07551829 |
| 140 | Hypothermia (HP:0002045) | 2.06787923 |
| 141 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05762952 |
| 142 | Hepatocellular necrosis (HP:0001404) | 2.04990810 |
| 143 | Severe muscular hypotonia (HP:0006829) | 2.04187005 |
| 144 | Opisthotonus (HP:0002179) | 2.03383369 |
| 145 | Genetic anticipation (HP:0003743) | 2.03369582 |
| 146 | Nephrolithiasis (HP:0000787) | 2.03339333 |
| 147 | Chorioretinal atrophy (HP:0000533) | 2.02094555 |
| 148 | Mitral stenosis (HP:0001718) | 2.01988274 |
| 149 | Congenital hepatic fibrosis (HP:0002612) | 2.01519499 |
| 150 | Pancreatitis (HP:0001733) | 2.00617844 |
| 151 | Hypoplasia of the pons (HP:0012110) | 2.00615175 |
| 152 | Hepatic necrosis (HP:0002605) | 2.00614376 |
| 153 | Irritability (HP:0000737) | 2.00421600 |
| 154 | Anencephaly (HP:0002323) | 2.00410782 |
| 155 | Malnutrition (HP:0004395) | 1.98286172 |
| 156 | Lipid accumulation in hepatocytes (HP:0006561) | 1.98212313 |
| 157 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.97844661 |
| 158 | Progressive cerebellar ataxia (HP:0002073) | 1.97783790 |
| 159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97258061 |
| 160 | Renal salt wasting (HP:0000127) | 1.96216901 |
| 161 | Optic disc pallor (HP:0000543) | 1.94327496 |
| 162 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.93635897 |
| 163 | Broad-based gait (HP:0002136) | 1.93137879 |
| 164 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.92769395 |
| 165 | Acute encephalopathy (HP:0006846) | 1.90363588 |
| 166 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.89684538 |
| 167 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.89684538 |
| 168 | Lissencephaly (HP:0001339) | 1.88868616 |
| 169 | Patellar aplasia (HP:0006443) | 1.87667850 |
| 170 | Male pseudohermaphroditism (HP:0000037) | 1.87112799 |
| 171 | Progressive macrocephaly (HP:0004481) | 1.85475973 |
| 172 | Febrile seizures (HP:0002373) | 1.85269143 |
| 173 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.84533349 |
| 174 | Gait imbalance (HP:0002141) | 1.84516093 |
| 175 | Tachypnea (HP:0002789) | 1.82258601 |
| 176 | Abnormal albumin level (HP:0012116) | 1.80828080 |
| 177 | Hypoalbuminemia (HP:0003073) | 1.80828080 |
| 178 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.78570771 |
| 179 | Abnormality of macular pigmentation (HP:0008002) | 1.78517306 |
| 180 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77549604 |
| 181 | Hemiparesis (HP:0001269) | 1.77143807 |
| 182 | Abnormal ciliary motility (HP:0012262) | 1.76508687 |
| 183 | Limb dystonia (HP:0002451) | 1.76398084 |
| 184 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76000934 |
| 185 | Stomach cancer (HP:0012126) | 1.74861741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.39883826 |
| 2 | INSRR | 4.15965817 |
| 3 | WNK4 | 3.87992648 |
| 4 | WNK3 | 3.78684864 |
| 5 | BCKDK | 3.71521034 |
| 6 | IRAK3 | 3.34988754 |
| 7 | OXSR1 | 3.25673816 |
| 8 | ZAK | 3.21813848 |
| 9 | MAP4K2 | 2.58186293 |
| 10 | STK38L | 2.49022679 |
| 11 | ACVR1B | 2.47261123 |
| 12 | FGFR4 | 2.44125932 |
| 13 | MAP3K14 | 2.28548960 |
| 14 | CASK | 2.15005347 |
| 15 | PINK1 | 2.06296463 |
| 16 | MAPK15 | 2.01100816 |
| 17 | TAOK3 | 1.91504499 |
| 18 | MAPK13 | 1.86564035 |
| 19 | IRAK2 | 1.84592631 |
| 20 | IRAK4 | 1.76790103 |
| 21 | TIE1 | 1.73179537 |
| 22 | DAPK2 | 1.72134999 |
| 23 | SGK2 | 1.72032012 |
| 24 | GRK1 | 1.69596113 |
| 25 | SIK1 | 1.64186219 |
| 26 | SGK223 | 1.56489049 |
| 27 | SGK494 | 1.56489049 |
| 28 | PHKG2 | 1.51112172 |
| 29 | PHKG1 | 1.51112172 |
| 30 | MAP3K4 | 1.45366311 |
| 31 | PIK3CG | 1.44535359 |
| 32 | AKT3 | 1.41404423 |
| 33 | PNCK | 1.40376994 |
| 34 | IRAK1 | 1.33303809 |
| 35 | MAP2K7 | 1.31871148 |
| 36 | TXK | 1.30730985 |
| 37 | ERBB4 | 1.26254028 |
| 38 | ADRBK1 | 1.21826487 |
| 39 | MARK1 | 1.16153124 |
| 40 | STK39 | 1.15737232 |
| 41 | CAMKK2 | 1.12420758 |
| 42 | MAPK11 | 1.11924722 |
| 43 | ERN1 | 1.10734214 |
| 44 | DYRK2 | 1.10404923 |
| 45 | SGK3 | 1.08204310 |
| 46 | TGFBR1 | 1.05629170 |
| 47 | PAK3 | 1.05365569 |
| 48 | MAPKAPK3 | 1.02709564 |
| 49 | BMPR2 | 1.02689546 |
| 50 | TYK2 | 1.00286626 |
| 51 | NTRK3 | 0.94343106 |
| 52 | BMPR1B | 0.93764812 |
| 53 | CDK3 | 0.91968435 |
| 54 | SIK3 | 0.91917684 |
| 55 | PRKAA2 | 0.89527763 |
| 56 | PLK4 | 0.87921236 |
| 57 | TEC | 0.82811866 |
| 58 | ADRBK2 | 0.81678641 |
| 59 | PKN1 | 0.81636916 |
| 60 | MAPKAPK5 | 0.81586635 |
| 61 | IKBKE | 0.80992792 |
| 62 | YES1 | 0.79159253 |
| 63 | MST1R | 0.73650749 |
| 64 | JAK1 | 0.71744650 |
| 65 | KDR | 0.71475702 |
| 66 | TAOK2 | 0.71349987 |
| 67 | NEK9 | 0.71164471 |
| 68 | PLK2 | 0.70933187 |
| 69 | PDK2 | 0.70214270 |
| 70 | FRK | 0.69537235 |
| 71 | MAPK7 | 0.68856791 |
| 72 | NME1 | 0.68416531 |
| 73 | EIF2AK2 | 0.67709466 |
| 74 | MKNK2 | 0.67188712 |
| 75 | EPHA4 | 0.65212473 |
| 76 | PRKAA1 | 0.64988478 |
| 77 | IKBKB | 0.64839506 |
| 78 | BTK | 0.64473071 |
| 79 | VRK1 | 0.64056295 |
| 80 | TGFBR2 | 0.63011959 |
| 81 | MAPK4 | 0.62954895 |
| 82 | NEK6 | 0.61878623 |
| 83 | CSNK1G2 | 0.61810461 |
| 84 | MAP3K7 | 0.61445866 |
| 85 | NUAK1 | 0.61231455 |
| 86 | CSNK1G1 | 0.60483652 |
| 87 | PTK2B | 0.60056892 |
| 88 | CHUK | 0.59994483 |
| 89 | GRK7 | 0.59647352 |
| 90 | PRKCI | 0.59440949 |
| 91 | CAMK1 | 0.59298093 |
| 92 | EPHA3 | 0.58494907 |
| 93 | CAMK1D | 0.58192559 |
| 94 | ABL2 | 0.58138131 |
| 95 | NEK2 | 0.57881644 |
| 96 | FGFR2 | 0.56948251 |
| 97 | PBK | 0.55824512 |
| 98 | CAMK2A | 0.55604953 |
| 99 | BRSK2 | 0.54235724 |
| 100 | NLK | 0.53474257 |
| 101 | TRIM28 | 0.53318405 |
| 102 | CSNK1G3 | 0.50290159 |
| 103 | FLT3 | 0.49130323 |
| 104 | NTRK2 | 0.48894269 |
| 105 | MAP2K4 | 0.48216842 |
| 106 | MYLK | 0.47731670 |
| 107 | STK4 | 0.46514162 |
| 108 | JAK2 | 0.46333228 |
| 109 | RPS6KA5 | 0.45668585 |
| 110 | GRK6 | 0.45443369 |
| 111 | * PRKACA | 0.44894035 |
| 112 | JAK3 | 0.44796690 |
| 113 | STK11 | 0.44755073 |
| 114 | STK16 | 0.44414326 |
| 115 | CAMK4 | 0.43137584 |
| 116 | WEE1 | 0.42396969 |
| 117 | MAP2K6 | 0.42330482 |
| 118 | TNK2 | 0.41504163 |
| 119 | DYRK1B | 0.41181003 |
| 120 | PRKCE | 0.40444257 |
| 121 | PRKD2 | 0.39579907 |
| 122 | CSNK1A1 | 0.39370824 |
| 123 | SGK1 | 0.39242389 |
| 124 | PRKCQ | 0.38224619 |
| 125 | CSNK1A1L | 0.38165447 |
| 126 | PRKACG | 0.38112737 |
| 127 | PRKG1 | 0.38043022 |
| 128 | OBSCN | 0.37276872 |
| 129 | PIM1 | 0.37195551 |
| 130 | MST4 | 0.37113763 |
| 131 | PRKCA | 0.36857330 |
| 132 | CAMK2G | 0.36509536 |
| 133 | GSK3A | 0.36423267 |
| 134 | PRKCZ | 0.36334847 |
| 135 | GRK5 | 0.35504155 |
| 136 | PIK3CA | 0.34412210 |
| 137 | CDK9 | 0.34401780 |
| 138 | CAMK1G | 0.33853922 |
| 139 | CSK | 0.33701415 |
| 140 | LYN | 0.33535762 |
| 141 | PRKCG | 0.33192393 |
| 142 | MAPK12 | 0.32993861 |
| 143 | PRKCD | 0.32737410 |
| 144 | LATS1 | 0.32593995 |
| 145 | KIT | 0.32559237 |
| 146 | TNIK | 0.32348358 |
| 147 | WNK1 | 0.32204305 |
| 148 | ITK | 0.30299777 |
| 149 | SIK2 | 0.30187772 |
| 150 | MUSK | 0.29878459 |
| 151 | MAP2K2 | 0.29592757 |
| 152 | CSNK1D | 0.29347482 |
| 153 | PLK3 | 0.28936973 |
| 154 | CAMKK1 | 0.27783026 |
| 155 | MKNK1 | 0.26909238 |
| 156 | MAP2K1 | 0.26397621 |
| 157 | CDK19 | 0.25651510 |
| 158 | EIF2AK3 | 0.25135016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.84213229 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.48958317 |
| 3 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.88279657 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.83046153 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.72730783 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.68703593 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58770014 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.57732133 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.56476451 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 2.56171711 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51299738 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41196962 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37281669 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34650628 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23759094 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17143380 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.15424597 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15145577 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.06273452 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04526038 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91642365 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.90655049 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.85672288 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.85658009 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85131722 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81095930 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80694271 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77595497 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74240491 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.70503163 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69172950 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68059519 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66625051 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62766704 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.61170536 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.57272696 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56832952 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.56105002 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55415501 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54002090 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.52415794 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.51911812 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51782096 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.48991127 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46389419 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45918078 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42467461 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41512243 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40551254 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35989136 |
| 51 | Protein export_Homo sapiens_hsa03060 | 1.35638016 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 1.35190978 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.34395395 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34089649 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.33791778 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.32799780 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31085070 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29758467 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29004292 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 1.23779225 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20045003 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14155434 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13925613 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 1.13243806 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 1.12986676 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11809158 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11118646 |
| 68 | * Morphine addiction_Homo sapiens_hsa05032 | 1.08965762 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08061610 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07061661 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06786703 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02014148 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94228216 |
| 74 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94114281 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92128186 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91257352 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.88878242 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88723031 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87498542 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87243776 |
| 81 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86094000 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79243936 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71969594 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69941534 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.66450052 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64237807 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64136977 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63132971 |
| 89 | * Purine metabolism_Homo sapiens_hsa00230 | 0.62135305 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.60864576 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58026269 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55554022 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49045078 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47101203 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46329672 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45829963 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44828690 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43536609 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43162374 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41899698 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41416494 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41246267 |
| 103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40644239 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39210912 |
| 105 | Ribosome_Homo sapiens_hsa03010 | 0.38356627 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38045560 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35080199 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.30076516 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26804074 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24931501 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21841108 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20096769 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15332890 |
| 114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15279777 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13507691 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.11685289 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.11558615 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10132717 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09369283 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.08182147 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08044871 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.05226118 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04197122 |
| 124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.03332441 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02995654 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02420573 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.02262426 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00021790 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | -0.0859907 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0841116 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0799400 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0666587 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0463479 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0398413 |
| 135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0353537 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0314759 |
| 137 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0182618 |
| 138 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0030346 |

